A tech bro coalition is exploring ways to genetically engineer embryos to stave off hereditary diseases, despite the practice being banned in the U.S.

Silicon Valley heavyweights Sam Altman of OpenAI and Coinbase founder Brian Armstrong are among the notable names investing in a mysterious startup called Preventive. It claims to have secured $30 million in investments to delve deeper into the complex world of embryo engineering.

Genetically engineering humans by tinkering with the genes in embryos is banned in the U.S., as well as in a range of other countries around the world—but not all of them.

The claims come according to a new report from the Wall Street Journal. It cites a source claiming that a couple with a genetic disease has been identified for the research.

Preventive CEO

See Full Page